The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Abstract
BACKGROUND: The pathophysiology of heart failure with normal ejection fraction (HFNEF) is still under discussion. Here we report the influence of cardiac inflammation on extracellular matrix (ECM) remodeling in patients with HFNEF. METHODS AND RESULTS: We investigated left ventricular systolic and diastolic function in 20 patients with HFNEF and 8 control patients by conductance catheter methods and echocardiography. Endomyocardial biopsy samples were also obtained, and ECM proteins as well as cardiac inflammatory cells were investigated. Primary human cardiac fibroblasts were outgrown from the endomyocardial biopsy samples to investigate the gene expression of ECM proteins after stimulation with transforming growth factor-β. Diastolic dysfunction was present in the HFNEF patients compared with the control patients. In endomyocardial biopsy samples from HFNEF patients, we found an accumulation of cardiac collagen, which was accompanied by a decrease in the major collagenase system (matrix metalloproteinase-1) in the heart. Moreover, a subset of inflammatory cells, which expressed the profibrotic growth factor transforming growth factor-β, could be documented in the HFNEF patients. Stimulation of primary human cardiac fibroblasts from HFNEF patients with transforming growth factor-β resulted in transdifferentiation of fibroblasts to myofibroblasts, which produced more collagen and decreased the amount of matrix metalloproteinase-1, the major collagenase in the human heart. A positive correlation between cardiac collagen, as well as the amount of inflammatory cells, and diastolic dysfunction was evident and suggests a direct influence of inflammation on fibrosis triggering diastolic dysfunction. CONCLUSIONS: Cardiac inflammation contributes to diastolic dysfunction in HFNEF by triggering the accumulation of ECM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The last two alterations are likely triggered by microvascular endothelial inflammation [70].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [70]
Citations
Cites
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P. N., Smiseth, O. A., Keulenaer, G. W. D., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,646
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,959
Zile, M. R., Baicu, C. F., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032566 · Cited by 1,577
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,185
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,139
Souders, C. A., Bowers, S., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 1,018
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 735
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Borlaug, B. A., Melenovsky, V., Russell, S. D., Kessler, K., Pacak, K., Becker, L. C., & Kass, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.632745 · Cited by 699
Cited by
Sorted by citations
Items 601–638 of 638
Tantawy, M., Langaee, T. Y., Wang, D., Rubinstein, S. M., Cornell, R. F., Lenihan, D. J., Fradley, M. G., & Gong, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147795
Research Progress on the Relationship between Hyperuricemia and Cardiovascular Disease
蔡, 锦. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1492462
Lin, N.-T., Chen, T.-Y., Wu, X., Chang, Y., Tsai, C., Liao, C., Lai, T., Chang, C., Lee, B., Lu, C., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-02030-w
Echocardiography Dedicated to Small Animal Models (Rodents) in Non-Ischemic CardiomyopathiesPreprint
Sapalo, A. T., Neto, P. D. O., & Romano, M. M. D. (2025) · Preprints.org · doi:10.20944/preprints202505.1456.v1
Vascular Cell Adhesion Molecule 1 in Heart Failure—Stuck on You
Patel, R. B. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.1600
吕, 佳. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1572118
Trusov, Y. A. (2025) · Aspirantskiy Vestnik Povolzhiya · doi:10.35693/avp681776
Rweished, N., Rokach, Y., Parnasa, E., Abedat, S., Bsoul, A., Nachman, D., Amir, O., Safadi, R., & Asleh, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.02.686066
Ma, J., Zhao, J., & Jia, G. (2025) · European journal of medical research · doi:10.1186/s40001-025-03381-x
Çakan, F., Köktürk, U., Çöllüoğlu, T., Adar, A., Akın, Y., & Önalan, O. (2025) · Medical Journal of Western Black Sea · doi:10.29058/mjwbs.1803743
Ge, Z., Han, J., Takaesu, F., Mishra, R., Sharma, S., Chen, L., Fu, X., Filipp, M. E., Wai, C. M., Shao, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.29.702616
Sapalo, A. T. (2025) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2025.tde-08092025-144619
Epigenomics and Epigenetics in Heart Failure with Preserved Ejection Fraction
Rabkin, S. W. (2026) · Heart Failure Clinics · doi:10.1016/j.hfc.2025.12.005
Swiderski, J., Gadanec, L. K., Hearth, S., Rowlands, B. D., Murphy, A. J., Apostolopoulos, V., & Zulli, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1756039
Zhao, Y., Chen, X.-Y., Zhu, G.-J., Cao, S.-Y., Zhou, Y., Zhao, L., Pu, J., Wu, J.-P., Huang, L., & Wu, L. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.112789
Rôle de la dysfonction endothéliale dans la physiopathologie de l'insuffisance cardiaque
Guimbal, S. (2020) · theses.fr (ABES) · doi:10.70675/293b97bezffdfz4208z86aez69830e83be3d
Rôle des péricytes et des cellules endothéliales dans l'insuffisance cardiaque
Cornuault, L. (2022) · theses.fr (ABES) · doi:10.70675/902151b1zd809z4b09z9562zd16a859cc3f2
Pieronne-Deperrois, M. (2022) · theses.fr (ABES) · doi:10.70675/71ef46cfz0230z4862za32aze1072fe4be66
Protective effect of SGLT2 inhibitors on cardiovascular remodeling
Matsushita, K. (2022) · theses.fr (ABES) · doi:10.70675/a461e811zf66fz4443za0efz481618885013
Fernández-Topham, J., Guerrero‐Hurtado, M., del Álamo, J. C., Bermejo, J., & Martínez‐Legazpi, P. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00109.2026
Những tiến bộ trong điều trị suy tim
Lợi, Đ. D., & Hoài, N. T. T. (2018) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.8485.2018.1131
Các biện pháp điều trị trong suy tim tiến triển
Hoài, N. T. T., Hùng, P. M., Cường, T. M., & Hiếu, T. B. (2018) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.8485.2018.1130
Riaz, M., Ghanwani, A., Khan, M., Sahjwani, V., Kumar, V., Farooqui, U. F., Gul, H., Said, M., Shah, S., Qazi, M. S., et al. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000005130
Chu, S., Casanova, F., Bala, R., Howes, O. D., Osimo, E. F., de Marvao, A., Ardissino, M., O’Regan, D. P., McIntosh, A., Strawbridge, R. J., et al. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100783
HFpEF as a diabetic complication: the central role of microvascular dysfunction
Nagai, Y., Matoba, K., & Nishimura, R. (2026) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-026-00023-6
Yttergren, S. T., Mamsen, L. S., Ougaard, M., Thisted, L., Hansen, H. H., & Roostalu, U. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.30.735488
Heart failure with mildly reduced ejection fraction (HFmrEF): where are we now?
Memon, M., Qadeer, Y. K., Virk, H. U. H., Rizwan, A. M., Coomar, P. P., Alam, M., Khawaja, M., Rivera, M. R. R., Tang, W. H. W., & Krittanawong, C. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10646-y
Balasa, E. A., Capone, F., Vacca, A., Fioretto, P., Catena, C., Tromp, J., Foo, R., Wang, Y., Lam, C. S. P., & Schiattarella, G. G. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.06.030
Molecular Mechanisms Governing Vascular Function in Heart Failure
Garrido‐Moreno, V., Ferdous, A., Gillette, T. G., & Hill, J. A. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.323132
Moradi, A., Ramey, K., Tabbaa, K., Sahyouni, A., Garcez, K. S., KUMAR, S., Pan, E. H., Barton, G., Oyesanmi, O., & Subbiondo, R. J. (2026) · Pathophysiology · doi:10.3390/pathophysiology33030063
Lyu, Y., Hou, J., Ma, I., Mostoufi, T., Jiang, Y., Yang, X., & Gao, W. D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177736
Immunometabolic regulation of cardiac macrophages in heart failure with preserved ejection fraction
Liang, J., Su, M., Liu, R., Li, T., Qin, Z., & Wáng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1896936
Zhang, Y., Wu, W., Zhai, X., Zhang, J., Wang, W., Huang, X., & Wu, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1927962
Packer, M., Butler, J., Zannad, F., Vaduganathan, M., & Borlaug, B. A. (2026) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2026.09.029
Yılmaz, R., Toprak, K., Karagoz, A., Yontar, O. C., Yolcu, M., Turan, Y., Boyacı, F., Ovaz, O. O., Yilmaz, E. K., Öztürk, E. F., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1934817
Hu, L., & Yang, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1989794
Huang, C., Lin, Y.-L., Lin, T., Wu, C., Wang, Y., & Lin, L. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.053485
Metadata
- Authors
- Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., Poller, W., Schultheiss, H.-P., & Tschöpe, C.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Cardiology and Pneumology (D.W., D.L., M.K., C.Z., K.S., F.E., J.v.S., C.S., A.R., W.P., H.-P.S., C.T.), Charité, Universititäts-Medizin Berlin, Campus Benjamin Franklin, Berlin, Germany, and Department of Cardiology (P.S.), Leiden University Medical Center, Leiden, The Netherlands.
- ORCID
- Venue
- Circulation Heart Failure
- Published
- 2011-01
- Volume
- 4
- Issue
- 1
- Pages
- 44-52
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2131184290
- Cited by
- 644
- References
- 55
- Citations by year
- 2026: 32 · 2025: 48 · 2024: 53 · 2023: 50 · 2022: 57 · 2021: 58 · 2020: 49 · 2019: 37 · 2018: 45 · 2017: 49 · 2016: 35 · 2015: 42 · 2014: 30 · 2013: 21 · 2012: 17
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Heart Failure (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure with preserved ejection fraction, cardiac inflammation, extracellular matrix remodeling, diastolic dysfunction, myocardial fibrosis, collagen deposition, MMP-1, TGF-beta, myofibroblasts, endomyocardial biopsy, left ventricular systolic function
- MeSH terms
- Adult, Aged, Biopsy, Cells, Cultured, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibrosis, Heart, Heart Failure, Humans, Inflammation, Male, Middle Aged, Myocardium, Stroke Volume, Case-Control Studies, Transforming Growth Factor beta, Ventricular Function, Left, Extracellular Matrix Proteins, Disease Progression, Matrix Metalloproteinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review